Literature DB >> 1915570

Blockade of morphine place conditioning by the CCKA receptor antagonist devazepide.

G A Higgins1, P Nguyen, E M Sellers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1915570     DOI： 10.1016/0014-2999(91)90528-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  4 in total

1.  The CCKB antagonist PD-134,308 facilitates rewarding effects of endogenous enkephalins but does not induce place preference in rats.

Authors:  O Valverde; M C Fournie-Zaluski; B P Roques; R Maldonado
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

2.  Devazepide, a CCKA receptor antagonist, impairs the acquisition of conditioned reward and conditioned activity.

Authors:  S A Josselyn; V P Franco; F J Vaccarino
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

Review 3.  Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction.

Authors:  B P Roques; F Noble
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

4.  Neural circuit mechanisms of the cholecystokinin (CCK) neuropeptide system in addiction.

Authors:  Yihe Ma; William J Giardino
Journal:  Addict Neurosci       Date:  2022-06-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.